These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 25517603

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S, Legood R, Alavi Y, Lindfield R, Sharma T, Kuper H, Polack S.
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [Abstract] [Full Text] [Related]

  • 3. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
    Chan CK, Gangwani RA, McGhee SM, Lian J, Wong DS.
    Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
    [Abstract] [Full Text] [Related]

  • 4. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.
    van Katwyk S, Jin YP, Trope GE, Buys Y, Masucci L, Wedge R, Flanagan J, Brent MH, El-Defrawy S, Tu HA, Thavorn K.
    Value Health; 2017 Sep; 20(8):1034-1040. PubMed ID: 28964434
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV, Tan GS, Tapp RJ, Mital S, Ting DS, Wong HT, Tan CS, Laude A, Tai ES, Tan NC, Finkelstein EA, Wong TY, Lamoureux EL.
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [Abstract] [Full Text] [Related]

  • 6. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
    Lin S, Ma Y, Xu Y, Lu L, He J, Zhu J, Peng Y, Yu T, Congdon N, Zou H.
    JMIR Public Health Surveill; 2023 Feb 23; 9():e41624. PubMed ID: 36821353
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
    Li H, Li G, Li N, Liu C, Yuan Z, Gao Q, Hao S, Fan S, Yang J.
    PLoS One; 2023 Feb 23; 18(11):e0291390. PubMed ID: 37971984
    [Abstract] [Full Text] [Related]

  • 8. Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study.
    Eye Care Comparative Effectiveness Research Team (ECCERT), Hiratsuka Y, Yamada M, Akune Y, Murakami A, Okada AA, Yamashita H, Ohashi Y, Yamagishi N, Tamura H, Fukuhara S, Takura T.
    Jpn J Ophthalmol; 2013 Jul 23; 57(4):391-401. PubMed ID: 23588297
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.
    Kirkizlar E, Serban N, Sisson JA, Swann JL, Barnes CS, Williams MD.
    Ophthalmology; 2013 Dec 23; 120(12):2604-2610. PubMed ID: 24084501
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi.
    Vetrini D, Kiire CA, Burgess PI, Harding SP, Kayange PC, Kalua K, Msukwa G, Beare NAV, Madan J.
    PLoS One; 2018 Dec 23; 13(1):e0190742. PubMed ID: 29300755
    [Abstract] [Full Text] [Related]

  • 12. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.
    Clin Gastroenterol Hepatol; 2013 Sep 23; 11(9):1158-66. PubMed ID: 23542330
    [Abstract] [Full Text] [Related]

  • 13. The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study.
    Tamura H, Goto R, Akune Y, Hiratsuka Y, Hiragi S, Yamada M.
    PLoS One; 2015 Sep 23; 10(7):e0133628. PubMed ID: 26214804
    [Abstract] [Full Text] [Related]

  • 14. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System.
    Ben ÂJ, Neyeloff JL, de Souza CF, Rosses APO, de Araujo AL, Szortika A, Locatelli F, de Carvalho G, Neumann CR.
    Appl Health Econ Health Policy; 2020 Feb 23; 18(1):57-68. PubMed ID: 31674001
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan.
    Maeda K, Shimbo T, Fukui T.
    J Med Screen; 2004 Feb 23; 11(2):97-102. PubMed ID: 15153326
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma.
    Yamada M, Nakano T, Matsuda H, Kim SW, Takagi Y.
    J Med Econ; 2020 Nov 23; 23(11):1293-1301. PubMed ID: 32729756
    [Abstract] [Full Text] [Related]

  • 17. Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach.
    Hofer F, Kauczor HU, Stargardt T.
    Lung Cancer; 2018 Oct 23; 124():189-198. PubMed ID: 30268459
    [Abstract] [Full Text] [Related]

  • 18. Cost effectiveness and cost utility of an organized screening programme for glaucoma.
    Vaahtoranta-Lehtonen H, Tuulonen A, Aronen P, Sintonen H, Suoranta L, Kovanen N, Linna M, Läärä E, Malmivaara A.
    Acta Ophthalmol Scand; 2007 Aug 23; 85(5):508-18. PubMed ID: 17655612
    [Abstract] [Full Text] [Related]

  • 19. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
    Wielage RC, Bansal M, Andrews JS, Klein RW, Happich M.
    Appl Health Econ Health Policy; 2013 Jun 23; 11(3):219-36. PubMed ID: 23616247
    [Abstract] [Full Text] [Related]

  • 20. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
    Brown GC, Brown MM, Lieske HB, Lieske PA, Brown KS, Lane SS.
    Ophthalmology; 2011 Sep 23; 118(9):1834-43. PubMed ID: 21723614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.